Sign in
Active, not recruitingNo phase

Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection

Key facts

Who runs it
JOTEC GmbH
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
301 people enrolled
Started
12 Mar 2019
Expected to end
30 Jun 2030
Type of study
Observational
Treatments tested
  • Ascyrus Medical Dissection Stent (AMDS)
Record updated
9 February 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • ≥18 and ≤ 80 years of age (male or female)
  • One of the following diagnosed within 14 days:; Acute DeBakey type I dissection based on CT angiography; or; IMH based on CT angiography

Who cannot take part

  • Uncontrolled systemic infection
  • Known allergy(ies) to nitinol and/ or PTFE
  • < 18 years of age or > 80 years of age (male or female)
  • General Exclusion Criteria:
  • Unwilling to comply with the follow-up schedule
  • Refusal to give Informed Consent; Medical Exclusion Criteria:
  • Uncontrollable anaphylaxis to iodinated contrast
  • Patient in extreme hemodynamic compromise requiring cardiopulmonary resuscitation (CPR)
  • Preoperative coma; Anatomical Exclusion Criteria:
  • Any pathology of mycotic origin
  • Subacute or chronic dissection of the ascending aorta and aortic arch (>14 days after the index event)
  • Aortic fistulous communication with non-vascular structure (e.g. esophagus, bronchial)
  • Extensive thrombus or calcification in the aortic arch as defined by CT angiography
  • Excessive tortuosity precluding safe passage of the AMDS as defined by CT angiography

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this registry is to collect information on the performance and clinical benefits of the AMDS (Ascyrus Medical Dissection Stent) to treat patients with acute "DeBakey type I dissections" and with or without so called "preoperative clinically relevant malperfusion" and/or "intramural hematomas".

Read full original descriptionShow less

In a healthy aorta (the vessel that supplies blood to most of the body) the blood flows freely through the main lumen (a space inside the vessel where blood flows). The participants involved in this study have a tear that has separated the inner layer of the aorta wall and created a secondary channel (false lumen) in addition to the main channel (true lumen), and huts, the blood flows through both channels.

AMDS is a stent (a metal tube helping to keep the vessel open) that is placed in the descending thoracic aorta. AMDS is a medical device commercially available in the countries in which the study is being conducted and it is used as standard of care according to its indication.

Treatments tested

  • Ascyrus Medical Dissection Stent (AMDS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Post-market Registry of the AMDS for the Treatment of Acute DeBakey Type I Dissection: PROTECT Registry
Record updated
9 February 2026